Indian beauty and personal care giant Biotique is going public next year and it’s a big moment for the 30 year old Ayurvedic brand. The company plans to raise USD 300 million (~INR 2,663 crore) by diluting 10% of equity, valuing the company at USD 3 billion (~INR 26,630 crore), says founder and chairperson Vinita Jain.
Biotique IPO—expected to be one of the biggest in India’s consumer goods space—shows the growing appetite for natural and wellness driven beauty products. Biotique is in talks with ICICI Securities, Kotak Mahindra Capital, Motilal Oswal, and IIFL to manage the issue.
From Ayurvedic Roots to Modern Markets
Founded in 1992, Biotique has built its identity on Ayurvedic science and has a portfolio of skincare, haircare, makeup and baby care products. The company’s debt free balance sheet and refusal to take private equity funding has given it operational independence—a rarity in today’s investor driven beauty space.
Biotique’s parent company Bio Veda Action Research emphasizes products made from organically grown, preservative free botanical extracts. This has kept the brand at the intersection of authenticity and sustainability two attributes that are increasingly important for millennials and Gen Z.
Biotique IPO Objectives: Innovation & Global Expansion
Funds from Biotique IPO will be used in four areas:
- Research & Development – To create new formulations using Ayurvedic and plant based science.
- Domestic Distribution Expansion – Strengthening presence in Tier 2 and Tier 3 cities of India.
- International Growth – Deepen Biotique’s presence in export markets in Asia, Europe and Middle East.
- Building a House of Brands – Establish or acquire other beauty brands under the Biotique umbrella.
Vinita Jain has called the IPO a legacy decision to ensure “the longevity of the company through public ownership”.
The Market Context
Biotique IPO comes at a time when India’s beauty and personal care (BPC) market is booming like never before.
According to a Nykaa–Redseer report, the sector is expected to grow from USD 20 billion (~INR 1.77 lakh crore) in 2024 to USD 34 billion (~INR 30.18 lakh crore) by 2028 at a 10–11% compound annual growth rate (CAGR) making India the fastest growing beauty market globally.
This growth is driven by:
- Rapid urbanization and rising disposable incomes.
- Global beauty brands entering India (e.g., Sephora, H&M Beauty, and Fenty Beauty).
- E-commerce platforms like Nykaa, Tira, and Amazon Beauty.
- Growing consumer trust in Ayurvedic and “clean” beauty formulations.
In this new landscape Biotique’s Ayurvedic heritage puts it in a sweet spot between global entrants and homegrown digital first D2C players.
Recent Updates and Brand Evolution
Biotique appointed Sara Ali Khan as its brand ambassador last year, a move that marks a shift towards mainstream visibility. The company has historically been low-key with its marketing, relying on word-of-mouth and product credibility.
The endorsement signals Biotique’s intention to connect with India’s youth and project a new, aspirational image—bridging ancient wellness and modern beauty.
A Strategic and Symbolic IPO
Biotique IPO is more than a fund raise—it’s the official market recognition of India’s Ayurvedic beauty segment. At a USD 3 billion valuation, the company is on par with Nykaa and Mamaearth, indicating a mature ecosystem where heritage brands and digital disruptors are vying for investor trust.
For investors, Biotique IPO offers:
- Profitability and no debt, unlike many venture-backed startups.
- High growth market, with traditional trust and global demand.
- Strategic expansion, with clear investment in R&D and international scalability.
The challenge will be to maintain Ayurvedic authenticity while achieving scale and transparency that comes with being a listed company.
Outlook
As Biotique gears up for its 2026 IPO, the company is in a phase of operational consolidation and regulatory preparation. With India’s beauty and personal care industry entering a growth cycle, Biotique’s timing seems both deliberate and timely.
If successful, Biotique IPO will be a milestone—not just for the company but for the Ayurvedic beauty movement, proving that ancient wisdom and modern capital can coexist profitably.
For more details related to IPO GMP, SEBI IPO Approval, and Live Subscription stay tuned to IPO Central.